| Huntington’s disease in Israel: A population-based study using 20 years of routinely-collected healthcare data N Gavrielov-Yusim, Y Barer, M Martinec, A Siadimas, S Roumpanis, ... Journal of Huntington's Disease 10 (4), 469-477, 2021 | 5 | 2021 |
| Electronic health record data for assessing risk of hospitalization for COVID-19: Methodological considerations applied to multiple sclerosis P Dillon, A Siadimas, S Roumpanis, O Fajardo, K Fitovski, N Jessop, ... Multiple Sclerosis and Related Disorders 71, 104512, 2023 | 2 | 2023 |
| Evaluating digital twins for alzheimer’s disease using data from a completed Phase 2 clinical trial JR Walsh, S Roumpanis, D Bertolini, P Delmar Alzheimer's & Dementia 18, e065386, 2022 | 2 | 2022 |
| Clinical outcomes of COVID-19 in patients with multiple sclerosis treated with ocrelizumab in the pre-and post-SARS-Cov-2 vaccination periods: Insights from Israel J Weberpals, S Roumpanis, Y Barer, S Ehrlich, N Jessop, R Pedotti, ... Multiple Sclerosis and Related Disorders 68, 104153, 2022 | 2 | 2022 |
| Disease Burden of spinal muscular atrophy: a comparative cohort study using insurance Claims Data in the USA J Mouchet, S Roumpanis, E Gaki, S Lipnick, M Oskoui, RS Scalco, ... Journal of Neuromuscular Diseases 10 (1), 41-53, 2023 | 1 | 2023 |
| Validity of an electronic health record (EHR) and claims-derived proxy measure of multiple sclerosis (MS) disability P Dillon, S Roumpanis, EM Le Rouzic PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 31, 443-444, 2022 | 1 | 2022 |
| A real-world data study of coronavirus-2019 disease severity in patients with multiple sclerosis treated with ocrelizumab P Dillon, A Waqar, S Roumpanis, M Martinec, ML Rouzic Multiple Sclerosis Journal, 103-104, 2020 | 1 | 2020 |
| Chronic use of anti-epileptic drugs in Angelman syndrome using claims data in the United States S Roumpanis, M Johnson, T Wiese, P Novak Journal of the Neurological Sciences 455, 2023 | | 2023 |
| PB1243 Comparison of Quality of Life and Bleeding Phenotypes in People with Congenital Hemophilia A: Longitudinal Study from the PicnicHealth Database of PROMIS®-29 v2. 0 Scores J Scrimshire, S Roumpanis, M Aizenas, G Hanson, E Cibelli, K Patel, ... Research and Practice in Thrombosis and Haemostasis 7, 101136, 2023 | | 2023 |
| PB1250 Quality of Life in Females and Males with Mild Congenital Hemophilia A: A Longitudinal Study from the PicnicHealth Database of PROMIS®-29 v2. 0 Scores A Weyand, F Nissen, S Roumpanis, K Moreno, D Rosenfelt, G Hanson, ... Research and Practice in Thrombosis and Haemostasis 7, 101142, 2023 | | 2023 |
| SMA-CLINICAL: P. 83 A search for systemic manifestations of spinal muscular atrophy (SMA): A matched-cohort study using insurance claims data in the USA J Mouchet, M Oskoui, S Lipnick, S Roumpanis, R Naik, E Regulier, ... Neuromuscular Disorders 30, S71, 2020 | | 2020 |
| Treatment patterns in people with Parkinson's disease in the United States and the association with cardiovascular disease LCA Rutten-Jacobs, S Roumpanis, Y Liu, PM Coloma PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 29, 251-251, 2020 | | 2020 |
| Association between prediagnostic symptoms and patterns of treatment initiation in people with Parkinson's disease in the United Kingdom L Rutten-Jacobs, S Roumpanis, Y Liu, P Coloma MOVEMENT DISORDERS 35, S84-S85, 2020 | | 2020 |
| Longitudinal association between UPDRS and health-related quality of life in people with Parkinson's disease A Reyes, L Rutten-Jacobs, S Roumpanis, S Jauss, P Coloma MOVEMENT DISORDERS 35, S563-S563, 2020 | | 2020 |
| A Search for Systemic Manifestations of Spinal Muscular Atrophy (SMA): A Matched-Cohort Study Using Insurance Claims Data in the USA (1258) J Mouchet, S Lipnick, S Roumpanis, R Naik, E Regulier, R Scalco, ... Neurology 94 (15 Supplement), 2020 | | 2020 |
| Use of Benzodiazepines in People with Autism Spectrum Disorder in the United States S Roumpanis, M Johnson, C Liu, M del Valle Rubido INSAR 2020 Virtual Meeting, 0 | | |
